Castle Biosciences, Inc. · NASDAQ:CSTL

Oelschlager Kristen M sold 24,602 Castle Biosciences, Inc. shares (Form 4)

Traded Aug 24 to Aug 25, 2026 · Filed Aug 26, 2026

From Aug 24 to Aug 25, 2026, Oelschlager Kristen M (Chief Operating Officer) sold 24,602 Castle Biosciences, Inc. shares at an average US$34.06 for US$838K, leaving 72,649 shares. Filed Aug 26, 2026 (Form 4).

Sold
24,602 shares
Price
US$34.06 average (US$33.69 to US$34.64)
Value
US$838K
Holding after
72,649 shares (held indirectly)
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 24, 2026Common StockSale12,218US$33.6985,033Indirect
Aug 25, 2026Common StockSale7,161US$34.2677,872Indirect
Aug 25, 2026Common StockSale5,223US$34.6472,649Indirect

Source

View original at SEC

Related